Quantum Biopharma Ltd. Files March 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Mar 20, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their March 6-K, confirming 20-F filings.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on March 20, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing is a report of a foreign private issuer for the month of March 2025, indicating they file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's status as a foreign private issuer. It confirms their reporting structure and ongoing compliance with SEC regulations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the report
- FSD Pharma Inc. (company) — Former name of the filer
- March 20, 2025 (date) — Filing date
- Form 6-K (document) — Type of filing
- Form 20-F (document) — Annual report form filed by the company
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of March 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Which annual report form does Quantum Biopharma Ltd. file?
Quantum Biopharma Ltd. files its annual reports under cover of Form 20-F.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd. is headquartered at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The Standard Industrial Classification code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding Quantum Biopharma Ltd. (QNTM).